With 82 million people currently infected in Africa, the hepatitis B virus represents a major health threat. Early treatment can considerably reduce the risk of complications associated with the disease. In a recent analysis, scientists challenged the suitability of the diagnostic tests used in sub-Saharan Africa and called for more optimized treatment for local populations.

Find out more